Stocktoria
QHSLab, Inc. USAQ
QHSLab, Inc. (USAQ) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $2.7M at a 17.0% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Manufacturing · percentile among 1829 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.2 |
| Retained earnings / assets | -1.798 |
| EBIT / assets | 0.06 |
| Equity / liabilities | 2.976 |
Detailed pages
Sector peers · similar-size Manufacturing companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| USAQ | QHSLab, Inc. | 5/9 | -1.02 | 8.1 | — |
| OSRH | OSR Health, Inc. | 0/9 | 1.04 | — | — |
| INBS | INTELLIGENT BIO SOLUTIONS INC. | 2/9 | — | — | — |
| FEMY | FEMASYS INC | 2/9 | — | — | — |
| AURX | Nuo Therapeutics, Inc. | 3/9 | — | — | — |
| TNON | Tenon Medical, Inc. | 4/9 | — | — | — |
| ICU | SeaStar Medical Holding Corp | 3/9 | — | — | — |
FAQ
Is USAQ financially healthy?
QHSLab, Inc.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does USAQ pay a dividend?
No, QHSLab, Inc. does not currently pay a dividend.
How profitable is USAQ?
In FY2025, QHSLab, Inc. had a net margin of 17.0% and a return on equity of 28.1%.
Source: SEC EDGAR filings · CIK 0000856984 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.